The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
A federal appeals court ruled that Boston Scientific Corp. and Johnson & Johnson each infringed cardiac stent patents held by the other company, the Wall Street Journal reported.
The outcome of the 10-year court battle is still murky, despite the ruling, which failed to determine “the question of who owes what to whom,” according to the journal.
Executives at Millipore Corp. earned healthy raises and bonuses after the Billerica laboratory equipment maker posted solid sales and earnings numbers last year, according to news reports.
Chairman, president and CEO Martin Madaus got a 33.5 percent boost, taking his total compensation for 2008 to $5.2 million, according to The Associated Press.
Google Inc. launched a $100 million venture capital fund aimed at finding and funding “the next big thing.”
As first reported by the Wall Street Journal, a pair of the Mountain View, Calif., search engine titan’s executives were tapped to lead the fund.
Google hired former entrepreneur William Maris to start Google Ventures and moved Rich Miner, a former executive in its mobile unit into the new venture fund, the journal reported.
Interleukin Genetics Inc. slipped further toward a de-listing from the New York Stock Exchange’s Amex board after the exchange rejected its plan to regain compliance.
The Waltham genetic biomarker maker originally fell from the exchange’s graces two days before Christmas last year, when its stockholders equity dropped below the $6 million threshold required by the NYSE and it posted five consecutive quarters of net and operating losses.
Interleukin said it appealed the decision and requested a hearing before the exchange’s listing qualifications panel to plead its case, which it expects to be slated with 45 days.
Officials at Aspect Medical Systems Inc. are delaying the company’s annual meeting to prepare for a possible proxy fight against two of its largest stockholders.
Officials at the Norwood-based brain-monitoring equipment maker said they needed “sufficient time to consider the potential director candidates, and provide shareholders with adequate time to consider the Board’s nominees,” according to a filing with the federal Securities and Exchange Commission.
A three-year trial comparing Abbott Laboratories‘ Xience V drug-eluting stent against its Taxus competitor from Boston Scientific Corp. showed that the Abbott device is much more effective three years after implantation.
The news, announced at an American College of Cardiology conference in Orlando, sent the Natick device goliath’s stock into a slight swoon. The Xience product is already outselling the Taxus, and the news promises to accelerate that trend.
Levitronix LLC named Suraj Kalia to its advisory board.
Kalia, a certified financial analyst who focuses on the medical device sphere, is a senior analyst at SMH Capital.
Waltham-based Levitronix makes
magnetically levitated bearing-free motors for blood pumps and ultra-pure fluid handling.
Inverness Medical Innovations Inc. will begin selling a rapid diagnostic test for Clostridium difficile associated disease developed by TechLab Inc.
The Blacksburg, Va.-based diagnostics developer, a 1989 spinoff from Virginia Tech’s Anaerobe Laboratory, developed the in vitro diagnostic to detect CDAD, a highly infectious cause of severe diarrhea and colitis that can kill elderly or immune-compromised patients.
The federal Food & Drug Administration recently cleared TechLab to make the C. Diff Quik Chek Complete test, which reveals results in 30 minutes, for the Waltham-based diagnostics maker.
ConforMIS Inc. added a pair of medical device industry veterans to its executive roster.
The Burlington orthopedic implant maker appointed Robert Phelps as SVP of sales and David Cerveny as general counsel and VP of intellectual property.
Phelps’ more than 25 years in medical devices includes stints at Biomet Inc., Biosphere Medical and Johnson & Johnson.
Four orthopedic device makers cleared federal criminal charges and a fifth “satisfactorily completed” its non-prosecution agreement with the U.S. Attorney’s office in Newark, the Dow Jones news service reported.
Aushon BioSystems Inc. landed a $6.5 million cash infusion from North Bridge Venture Partners, in part to fund its buyout of Thermo Fisher Scientific‘s SearchLight protein array business.
The Billerica-based device maker manufactures microarray instruments and consumables.
